Literature DB >> 24559087

Hepatoprotective effects of triterpenoids from Ganoderma cochlear.

Xing-Rong Peng1, Jie-Qing Liu, Cui-Fang Wang, Xu-Yang Li, Yi Shu, Lin Zhou, Ming-Hua Qiu.   

Abstract

Two novel trinorlanostanes, cochlates A and B (1 and 2), with a 3,4-seco-9,10-seco-9,19-cyclo skeleton, as well as six new triterpenoids, fornicatins D-F (3-5) and ganodercochlearins A-C (6-8), together with five known triterpenoids (9-13), were obtained from the fruiting bodies of Ganoderma cochlear. The structural elucidation was achieved by interpretation of spectroscopic data, and compounds 2 and 7a were further characterized by X-ray crystallographic analysis. Fornicatins A, D, and F (10, 3, and 5) and fredelin (13) lowered the ALT and AST levels in HepG2 cells treated with H2O2, suggesting that they could display in vivo hepatoprotective activities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24559087     DOI: 10.1021/np400323u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  9 in total

Review 1.  Historical and current perspectives on therapeutic potential of higher basidiomycetes: an overview.

Authors:  Ruby Varghese; Yogesh Bharat Dalvi; Prasad Y Lamrood; Bharat P Shinde; C K K Nair
Journal:  3 Biotech       Date:  2019-09-17       Impact factor: 2.406

2.  [20(22)E]-Lanostane Triterpenes from the Fungus Ganoderma australe.

Authors:  Lin Zhou; Li-Li Guo; Masahiko Isaka; Zheng-Hui Li; He-Ping Chen
Journal:  J Fungi (Basel)       Date:  2022-05-12

3.  Ganoderma Lucidum Triterpenoids Improve Maternal Separation-Induced Anxiety- and Depression-like Behaviors in Mice by Mitigating Inflammation in the Periphery and Brain.

Authors:  Xue Mi; Gui-Rong Zeng; Jie-Qing Liu; Zhou-Song Luo; Ling Zhang; Xiao-Man Dai; Wen-Ting Fang; Jing Zhang; Xiao-Chun Chen
Journal:  Nutrients       Date:  2022-05-28       Impact factor: 6.706

4.  Chemical constituents from Inonotus obliquus and their antitumor activities.

Authors:  Fenqin Zhao; Guiyang Xia; Lixia Chen; Junli Zhao; Zhanfang Xie; Feng Qiu; Guang Han
Journal:  J Nat Med       Date:  2016-05-14       Impact factor: 2.343

Review 5.  Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review.

Authors:  Li Wang; Jie-Qing Li; Ji Zhang; Zhi-Min Li; Hong-Gao Liu; Yuan-Zhong Wang
Journal:  RSC Adv       Date:  2020-11-18       Impact factor: 4.036

6.  Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense.

Authors:  Ya Gao; Lihan Zhu; Jing Guo; Ting Yuan; Liqing Wang; Hua Li; Lixia Chen
Journal:  Oncotarget       Date:  2017-09-30

7.  Biophysical characterization of antibacterial compounds derived from pathogenic fungi Ganoderma boninense.

Authors:  Syahriel Abdullah; Yoon Sin Oh; Min-Kyu Kwak; KhimPhin Chong
Journal:  J Microbiol       Date:  2020-12-23       Impact factor: 3.422

8.  Rearranged lanostane-type triterpenoids with anti-hepatic fibrosis activities from Ganoderma applanatum.

Authors:  Lei Li; Xing-Rong Peng; Jin-Run Dong; Shuang-Yang Lu; Xiao-Nian Li; Lin Zhou; Ming-Hua Qiu
Journal:  RSC Adv       Date:  2018-09-05       Impact factor: 3.361

9.  Polysaccharide-Rich Fractions from Ganoderma resinaceum (Ganodermataceae) as Chemopreventive Agents in N-Diethylnitrosamine-Induced Hepatocellular Carcinoma in Wistar Rats.

Authors:  Marius Trésor Kemegne Sipping; Francine Kengne Mediesse; Larissa V Kenmogne; Judith Emery Ngomoyogoli Kanemoto; Dieudonné Njamen; Thaddée Boudjeko
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-12       Impact factor: 2.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.